New trial results out this week show that the antifibrinolytic tranexamic acid significantly reduces the risk of death due to bleeding, regardless of the cause, an international expert says. Speaking during the opening presidential session of Blood 2019, UK haematologist Professor Beverley Hunt said that while haemorrhage was the major cause of death in trauma ...
Another win for tranexamic acid in trauma related bleeding
By Nicola Garrett
21 Oct 2019